OPERATING BUSINESS SEGMENT AND INTERNATIONAL OPERATION INFORMATION (Tables)
|
12 Months Ended |
Dec. 31, 2015 |
|---|
| Segment Reporting [Abstract] |
|
| Schedule of reportable business segment information |
Reportable business segment information for the years ended December 31, 2015, 2014, and 2013 is as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2015 |
|
2014 |
|
2013 |
Net sales revenue: |
|
|
|
|
|
|
|
|
|
NSP Americas |
|
$ |
179,151 |
|
|
$ |
182,395 |
|
|
$ |
190,684 |
|
NSP Russia, Central and Eastern Europe |
|
27,408 |
|
|
50,274 |
|
|
62,747 |
|
Synergy WorldWide |
|
114,081 |
|
|
128,101 |
|
|
108,290 |
|
China and New Markets |
|
4,065 |
|
|
5,597 |
|
|
8,105 |
|
Total net sales revenue |
|
324,705 |
|
|
366,367 |
|
|
369,826 |
|
Contribution margin (1): |
|
|
|
|
|
|
|
|
|
NSP Americas |
|
74,953 |
|
|
74,603 |
|
|
78,171 |
|
NSP Russia, Central and Eastern Europe |
|
9,474 |
|
|
17,851 |
|
|
22,542 |
|
Synergy WorldWide |
|
35,277 |
|
|
43,888 |
|
|
38,011 |
|
China and New Markets |
|
1,870 |
|
|
2,633 |
|
|
3,242 |
|
Total contribution margin |
|
121,574 |
|
|
138,975 |
|
|
141,966 |
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
107,702 |
|
|
119,927 |
|
|
118,383 |
|
Operating income |
|
13,872 |
|
|
19,048 |
|
|
23,583 |
|
|
|
|
|
|
|
|
Other income (loss), net |
|
(592 |
) |
|
(34 |
) |
|
1,993 |
|
Income from continuing operations before provision for income taxes |
|
$ |
13,280 |
|
|
$ |
19,014 |
|
|
$ |
25,576 |
|
___________________________
(1) Contribution margin consists of net sales revenue less cost of sales and volume incentives expense.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2015 |
|
2014 |
|
2013 |
Capital expenditures: |
|
|
|
|
|
|
|
|
|
NSP Americas |
|
$ |
21,437 |
|
|
$ |
25,581 |
|
|
$ |
8,018 |
|
NSP Russia, Central and Eastern Europe |
|
— |
|
|
8 |
|
|
4 |
|
Synergy WorldWide |
|
302 |
|
|
1,321 |
|
|
534 |
|
China and New Markets |
|
487 |
|
|
— |
|
|
— |
|
Total capital expenditures |
|
$ |
22,226 |
|
|
$ |
26,910 |
|
|
$ |
8,556 |
|
|
|
|
|
|
|
|
Depreciation and amortization: |
|
|
|
|
|
|
|
|
|
NSP Americas |
|
$ |
3,603 |
|
|
$ |
3,438 |
|
|
$ |
3,568 |
|
NSP Russia, Central and Eastern Europe |
|
26 |
|
|
25 |
|
|
27 |
|
Synergy WorldWide |
|
885 |
|
|
946 |
|
|
871 |
|
China and New Markets |
|
11 |
|
|
— |
|
|
— |
|
Total depreciation and amortization |
|
$ |
4,525 |
|
|
$ |
4,409 |
|
|
$ |
4,466 |
|
|
|
|
|
|
|
|
|
|
|
As of December 31, |
|
2015 |
|
2014 |
Assets: |
|
|
|
|
|
|
NSP Americas |
|
$ |
141,428 |
|
|
$ |
129,371 |
|
NSP Russia, Central and Eastern Europe |
|
5,122 |
|
|
6,679 |
|
Synergy WorldWide |
|
38,048 |
|
|
40,797 |
|
China and New Markets |
|
15,922 |
|
|
19,952 |
|
Total assets |
|
$ |
200,520 |
|
|
$ |
196,799 |
|
|
| Schedule of consolidated net sales revenue by geographical locations |
From an individual country perspective, only the United States and South Korea comprises approximately 10 percent or more of consolidated net sales revenue for any of the years ended December 31, 2015, 2014, and 2013 as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2015 |
|
2014 |
|
2013 |
Net sales revenue: |
|
|
|
|
|
|
|
|
|
United States |
|
$ |
147,553 |
|
|
$ |
148,219 |
|
|
$ |
152,209 |
|
South Korea |
|
48,476 |
|
|
54,314 |
|
|
34,207 |
|
Other |
|
128,676 |
|
|
163,834 |
|
|
183,410 |
|
Total net sales revenue |
|
$ |
324,705 |
|
|
$ |
366,367 |
|
|
$ |
369,826 |
|
|
| Schedule of revenue generated by each of the Company's product lines |
Revenue generated by each of the Company’s product lines is set forth below (dollars in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, |
|
2015 |
|
2014 |
|
2013 |
NSP Americas: |
|
|
|
|
|
|
|
|
|
General health |
|
$ |
80,315 |
|
|
$ |
78,218 |
|
|
$ |
80,379 |
|
Immunity |
|
22,042 |
|
|
23,549 |
|
|
23,374 |
|
Cardiovascular |
|
12,331 |
|
|
12,566 |
|
|
13,018 |
|
Digestive |
|
49,239 |
|
|
53,133 |
|
|
55,936 |
|
Personal care |
|
3,575 |
|
|
4,000 |
|
|
5,162 |
|
Weight management |
|
11,649 |
|
|
10,929 |
|
|
12,815 |
|
|
|
179,151 |
|
|
182,395 |
|
|
190,684 |
|
NSP Russia, Central and Eastern Europe: |
|
|
|
|
|
|
|
|
|
General health |
|
$ |
11,433 |
|
|
$ |
18,841 |
|
|
$ |
22,690 |
|
Immunity |
|
3,328 |
|
|
6,512 |
|
|
7,902 |
|
Cardiovascular |
|
1,714 |
|
|
3,104 |
|
|
4,324 |
|
Digestive |
|
7,167 |
|
|
13,171 |
|
|
15,693 |
|
Personal care |
|
2,716 |
|
|
6,073 |
|
|
8,817 |
|
Weight management |
|
1,050 |
|
|
2,573 |
|
|
3,321 |
|
|
|
27,408 |
|
|
50,274 |
|
|
62,747 |
|
Synergy WorldWide: |
|
|
|
|
|
|
|
|
|
General health |
|
$ |
43,829 |
|
|
$ |
46,546 |
|
|
$ |
36,723 |
|
Immunity |
|
752 |
|
|
974 |
|
|
1,394 |
|
Cardiovascular |
|
34,191 |
|
|
42,449 |
|
|
42,154 |
|
Digestive |
|
17,746 |
|
|
20,839 |
|
|
16,897 |
|
Personal care |
|
5,697 |
|
|
7,196 |
|
|
7,097 |
|
Weight management |
|
11,866 |
|
|
10,097 |
|
|
4,025 |
|
|
|
114,081 |
|
|
128,101 |
|
|
108,290 |
|
China and New Markets: |
|
|
|
|
|
|
|
|
|
General health |
|
$ |
1,903 |
|
|
$ |
2,370 |
|
|
$ |
3,259 |
|
Immunity |
|
525 |
|
|
777 |
|
|
1,006 |
|
Cardiovascular |
|
292 |
|
|
334 |
|
|
461 |
|
Digestive |
|
1,011 |
|
|
1,608 |
|
|
2,365 |
|
Personal care |
|
93 |
|
|
108 |
|
|
126 |
|
Weight management |
|
241 |
|
|
400 |
|
|
888 |
|
|
|
4,065 |
|
|
5,597 |
|
|
8,105 |
|
Total net sales revenue |
|
$ |
324,705 |
|
|
$ |
366,367 |
|
|
$ |
369,826 |
|
|
| Schedule of consolidated property, plant and equipment by geographical locations |
From an individual country perspective, only the United States comprise 10 percent or more of consolidated property, plant and equipment as follows (dollar amounts in thousands):
|
|
|
|
|
|
|
|
|
|
As of December 31 |
|
2015 |
|
2014 |
Property, plant and equipment |
|
|
|
|
|
|
United States |
|
$ |
66,044 |
|
|
$ |
48,013 |
|
Other |
|
2,684 |
|
|
3,330 |
|
Total property, plant and equipment |
|
$ |
68,728 |
|
|
$ |
51,343 |
|
|